Skip to main content
ABVC BIOPHARMA, INC. logo

ABVC BIOPHARMA, INC. — Investor Relations & Filings

Ticker · ABVC ISIN · US00091F1066 US Manufacturing
Open in API
Filings indexed 780 across all filing types
Latest filing 2017-01-26 Regulatory Filings
Country US United States of America
Listing US ABVC

About ABVC BIOPHARMA, INC.

https://abvcpharma.com/

ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company that develops and commercializes drugs and medical devices to address unmet medical needs. The company focuses on advancing a pipeline of botanical, plant-based pharmaceuticals and medical technologies sourced from research institutions. Its therapeutic areas of focus include oncology, ophthalmology, and central nervous system disorders such as major depressive disorder (MDD) and adult attention-deficit/hyperactivity disorder (ADHD). Key products in development include Vitargus®, a biodegradable vitreous substitute for eye surgery, and botanical drug candidates for MDD and ADHD. Additionally, its subsidiary, BioKey, Inc., offers contract development and manufacturing services for nutritional and pharmaceutical products.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2017
Regulatory Filings
2017-01-26 English
AMENDMENT NO. 2 TO REGISTRATION STATEMENT
Regulatory Filings Classification · 100% confidence The document is an Amendment No. 2 to a Form S-1 Registration Statement filed with the SEC under the Securities Act of 1933. It includes detailed information about the registration of securities, selling stockholders, offering price, and other regulatory disclosures typical of a registration statement for securities offerings. The document is not a financial report, earnings release, or management discussion but a regulatory filing related to securities registration and offering. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous SEC filings that do not fit other specific categories.
2017-01-19 English
WITHDRAWAL OF AMENDMENT TO A REGISTRATION STATEMENT
Regulatory Filings Classification · 100% confidence The document is a letter withdrawing an amendment to a registration statement (Form S-1/A) and re-filing it under the correct file number. It is a regulatory communication related to the registration process, not a financial report, earnings release, or other specific filing type. The document is short (1056 characters) and serves as a formal notice to a regulatory office. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance documents that do not fit other categories.
2017-01-19 English
AMENDMENT NO. 2 TO REGISTRATION STATEMENT
Capital/Financing Update Classification · 95% confidence The document is an Amendment No. 2 to a Form S-1 Registration Statement filed with the SEC. It includes detailed information about the registration of securities, selling stockholders, offering price, and company background. The Form S-1 is a registration statement used for initial public offerings or other securities offerings under the Securities Act of 1933. This document is not an annual report, earnings release, or any other financial report but a capital markets filing related to securities registration and offering. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains detailed offering and registration information, not just an announcement or notice, so it is not a Report Publication Announcement or Regulatory Filing. Hence, the classification is CAP with high confidence.
2017-01-12 English
Regulatory Filings 2017
Regulatory Filings Classification · 95% confidence The document is a detailed response letter to the SEC staff comments regarding a Registration Statement on Form S-1 filed by American Brivision (Holding) Corporation. It discusses amendments to the Registration Statement, clinical trial disclosures, risk factors, intellectual property, executive compensation, selling stockholders, and audit firm details. The document references Amendment No. 2 to the Form S-1 and includes detailed regulatory compliance and disclosure updates. This type of document is characteristic of correspondence related to a registration statement filing, which is a regulatory filing but not a financial report like an Annual Report or Earnings Release. It is not a report publication announcement since it contains substantive responses and revisions, not just a notice. It is not a certification or attestation letter. Therefore, the best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2017-01-12 English
ANNUAL REPORT
Annual Report FY 2016
2017-01-12 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.